Qualification: M.Sc. (Zoology) & Ph.D (Biochemistry- Clinical Immunology) 

Dr. Sanchaita Misra, Ph.D. in Biochemistry (Clinical Immunology) from the University of Calcutta (2014-2023), is a life science researcher with over 8 years of experience in immunoblotting, confocal microscopy, and immunocytochemistry, specializing in chronic diseases like rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and oral cancer (OSCC-GB). She explores the dual role of DNT cells in oral cancer immunotherapy. Her expertise includes cell culture, flow cytometry, scRNA-seq data analysis, and animal models, with notable publications on anti-rheumatoid arthritis bioactive and IL-17 as a biomarker. She previously holds an ICMR-Senior Research Fellowship (2019). 

Thrust Area:  

• Rheumatoid Arthritis and Angiogenesis 
• Oral Cancer Immunotherapy 
• Antioxidant Therapies and Oxidative Stress 
• Tumor Biopsy and Molecular Analysis 
• Chronic inflammatory diseases 
• Cancer immunology and therapeutic innovation 

Publications:

• Misra, S., Mondal, S., Chatterjee, S., Guin, A., Sinhamahapatra, P., & Ghosh, A. (2018). Association of angiogenic and inflammatory markers with power Doppler ultrasound vascularity grade and DAS28-CRP in early rheumatoid arthritis: A comparative analysis. BioMed Research International, 2018, 1–8.  
• Saha, A., Bagchi, A., Chatterjee, S., Dutta, S., Misra, S., Bhattacharjee, D., Chatterjee, S., Mondal, S., Ghosh, P., Chatterjee, M., & Ghosh, A. (2020). Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis. Free Radical Research, 55(1), 1–3.  
• Chatterjee, S., Bhattacharjee, D., Misra, S., Saha, A., Bhattacharyya, N. P., & Ghosh, A. (2020). Increase in MEG3, MALAT1, NEAT1 significantly predicts the clinical parameters in patients with rheumatoid arthritis. Personalized Medicine, 17(6), 445–457. 
• Guin, A., Sinhamahapatra, P., Misra, S., Mazumder, S. R., Chatterjee, S., & Ghosh, A. (2019). Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration. Biomedical Journal, 42(6), 394–402.  
• Misra, S., Bagchi, A., Sarkar, A., Niyogi, S., Bhattacharjee, D., Chatterjee, S., Mondal, S., Chattopadhyay, A., Saha, A., Chatterjee, S., Sinhamahapatra, P., Chakrabarti, P., Chatterjee, M., & Ghosh, A. (2021). Methotrexate and theaflavin-3,3'-digallate synergistically restore the balance between apoptosis and autophagy in synovial fibroblasts of RA: An ex vivo approach with cultured human RA FLS. Inflammopharmacology, 29(5), 1427–1442. https://doi.org/10.1007/s10787-021-00857-0 
• Misra, S., Mondal, S., Chatterjee, S., Dutta, S., Sinha, D., Bhattacharjee, D., Lahiri, D., & Ghosh, A. (2022). Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis. Cytokine, 153, 155837. https://doi.org/10.1016/j.cyto.2022.155837 
• Mazumder, S. R., Misra, S., Guin, A., Paul, D. P., Chatterjee, M., & Ghosh, A. (2016). Immunomodulatory activity of black tea extract in rheumatoid arthritis: An in vitro study. International Journal of Advanced Research, 2(10), 5–11. 
• Misra, S., Ikbal, A. M., Bhattacharjee, D., Hore, M., Mishra, S., Karmakar, S., Ghosh, A., Srinivas, R., Das, A., Agarwal, S., & Saha, K. D. (2022). Validation of antioxidant, antiproliferative, and in vitro anti-rheumatoid arthritis activities of epigallocatechin-rich bioactive fraction from Camellia sinensis var. assamica, Assam variety white tea, and its comparative evaluation with green tea fraction. Journal of Food Biochemistry, 46(12), e14487.  
• Bhattacharjee, D., Mondal, S., Saha, A., Misra, S., Chatterjee, S., Rao, A., Sarkar, A., Chatterjee, S., Sinhamahapatra, P., & Ghosh, A. (2023). Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis. Clinical and Experimental Medicine, 23(3), 905–915.